Kiwifruit extracts inhibit cytokine production by lipopolysaccharide-activated macrophages, and intestinal epithelial cells isolated from IL10 gene deficient mice

Cellular Immunology

Volumn 270, Issue 1, 2011, Pages 70-79

  Edmunds, Shelley J ^a,b   Roy, Nicole C ^c,d   Love, Donald R ^b   Laing, William A ^a  

^a THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c AGRESEARCH GRASSLANDS   (New Zealand)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

Cytokines; IL10 gene deficient mouse; Intestinal epithelial cells; Kiwifruit; LPS signalling; Macrophages; Nitric oxide

Indexed keywords

CYTOKINE; ETHYL ACETATE EXTRACT; INTERLEUKIN 10; KIWIFRUIT EXTRACT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACTINIDIA CHINENSIS; ACTINIDIA DELICIOSA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; EXPERIMENTAL MODEL; INTESTINE EPITHELIUM CELL; KIWIFRUIT; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; WILD TYPE;

ACTINIDIA; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS;

ACTINIDIA CHINENSIS; ACTINIDIA DELICIOSA; MURINAE; MUS;

EID: 79959837987     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.04.004     Document Type: Article

References (63)

1. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 2002, 247:417-429.
2. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:390-407.
3. Chapman-Kiddell C.A., Davies P.S.W., Gillen L., Radford-Smith G.L. Role of diet in the development of inflammatory bowel disease. Inflamm. Bowel Dis. 2010, 16:137-151.
4. Mizoguchi A., Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J. Gastroenterol. 2008, 43:1-17.
5. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 2000, 68:7010-7017.
6. Mahida Y.R. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm. Bowel Dis. 2000, 6:21-33.
7. Kamada N., Hisamatsu T., Okamoto S., Chinen H., Kobayashi T., Sato T., Sakuraba A., Kitazume M.T., Sugita A., Koganei K., Akagawa K.S., Hibi T. Unique CD14+ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis. J. Clin. Invest. 2008, 118:2269-2280.
8. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
9. Kamada N., Hisamatsu T., Okamoto S., Sato T., Matsuoka K., Arai K., Nakai T., Hasegawa A., Inoue N., Watanabe N., Akagawa K.S., Hibi T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J. Immunol. 2005, 175:6900-6908.
10. Barnett M., McNabb W., Cookson A., Zhu S., Davy M., Knoch B., Nones K., Hodgkinson A., Roy N. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010, 11:39.
11. Oz H.S., Ray M., Chen T.S., McClain C.J. Efficacy of a transforming growth factor β2 containing nutritional support formula in a murine model of inflammatory bowel disease. J. Am. Coll. Nutr. 2004, 23:220-226.
12. Hegazi R.A.F., Saad R.S., Mady H., Matarese L.E., O'Keefe S., Kandil H.M. Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 2006, 22:275-282.
13. Roy N., Barnett M., Knoch B., Dommels Y., McNabb W. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res. 2007, 622:103-116.
14. Hale L.P., Chichlowski M., Trinh C.T., Greer P.K. Dietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis. Inflamm. Bowel Dis. 2010, 2012-2021.
15. Knoch B., Barnett M.P.G., McNabb W.C., Zhu S., Park Z.A., Khan A., Roy N.C. Dietary arachidonic acid-mediated effects on colon inflammation using transcriptome analysis. Mol. Nutr. Food Res. 2010, 54:S62-S74.
16. Larmonier C.B., Uno J.K., Lee K.-M., Karrasch T., Laubitz D., Thurston R., Midura-Kiela M.T., Ghishan F.K., Sartor R.B., Jobin C., Kiela P.R. Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10 dependent mechanism of protection. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 90365.
17. Ferguson A.R., Seal A.G. Kiwifruit. Temperate Fruit Crop Breeding 2008, 235-264. Springer, Netherlands. J.F. Hancock (Ed.).
18. Ferguson A.R., Ferguson L.R. Are kiwifruit really good for you?. Acta Hortic. 2002, 610:131-138.
19. Dawes H.M., Keene J.B. Phenolic composition of kiwifruit juice. J. Agric. Food Chem. 1999, 47:2398-2403.
20. McGhie T.K., Ainge G.D. Color in fruit of the genus Actinidia: carotenoid and chlorophyll compositions. J. Agric. Food Chem. 2002, 50:117-121.
21. Fiorentino A., D'Abrosca B., Pacifico S., Mastellone C., Scognamiglio M., Monaco P. Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits. J. Agric. Food Chem. 2009, 57:4148-4155.
22. Collins B.H., Horska A., Hotten P.M., Riddoch C., Collins A.R. Kiwifruit protects against oxidative DNA damage in human cells and in vitro. Nutr. Cancer 2001, 39:148-153.
23. Guo C., Yang J., Wei J., Li Y., Xu J., Jiang Y. Antioxidant activities of peel, pulp and seed fractions of common fruits as determined by FRAP assay. Nutr. Res. 2003, 23:1719-1726.
24. Jung K.-A., Song T.-C., Han D., Kim I.-H., Kim Y.-E., Lee C.H. Cardiovascular protective properties of kiwifruit extracts in vitro. Biol. Pharm. Bull. 2005, 28:1782-1785.
25. Du G., Li M., Ma F., Liang D. Antioxidant capacity and the relationship with polyphenol and vitamin C in Actinidia fruits. Food Chem. 2009, 113:557-562.
26. Collins A.R., Harrington V., Drew J., Melvin R. Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 2003, 24:511-515.
27. Rush E., Ferguson L.R., Cumin M., Thakur V., Karunasinghe N., Plank L. Kiwifruit consumption reduces DNA fragility: a randomized controlled pilot study in volunteers. Nutr. Res. 2006, 26:197-201.
28. Iwasawa H., Morita E., Ueda H., Yamazaki M. Influence of kiwi fruit on immunity and its anti-oxidant effects in mice. Food Sci. Technol. Res. 2010, 16:135-142.
29. Motohashi N., Shirataki Y., Kawase M., Tani S., Sakagami H., Satoh K., Kurihara T., Nakashima H., Mucsi I., Varga A., Molnar J. Cancer prevention and therapy with kiwifruit in Chinese folklore medicine: a study of kiwifruit extracts. J. Ethnopharmacol. 2002, 81:357-364.
30. Beck K., Conlon C.A., Kruger R., Coad J., Stonehouse W. Gold kiwifruit consumed with an iron-fortified breakfast cereal meal improves iron status in women with low iron stores: a 16-week randomised controlled trial. Br. J. Nutr. First View 2010, 1-8.
31. Watzl B., Bub A., Brandstetter B.R., Rechkemmer G. Modulation of human T-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br. J. Nutr. 1999, 82:383-389.
32. Hunter D.C., Denis M., Parlane N.A., Buddle B.M., Stevenson L.M., Skinner M.A. Feeding ZESPRI(TM) GOLD Kiwifruit puree to mice enhances serum immunoglobulins specific for ovalbumin and stimulates ovalbumin-specific mesenteric lymph node cell proliferation in response to orally administered ovalbumin. Nutr. Res. 2008, 28:251-257.
33. Shu Q., Mendis De Silva U., Chen S., Peng W., Ahmed M., Lu G., Yin Y., Liu A., Drummond L. Kiwifruit extract enhances markers of innate and acquired immunity in a murine model. Food Agric. Immunol. 2008, 19:149-161.
34. Rush E.C., Patel M., Plank L.D., Ferguson L.R. Kiwifruit promotes laxation in the elderly. Asia Pac. J. Clin. Nutr. 2002, 11:164-168.
35. Chan A.O.O., Leung G., Tong T., Wong N.Y. Increasing dietary fiber intake in terms of kiwifruit improves constipation in Chinese patients. World J. Gastroenterol. 2007, 13:4771-4775.
36. Murakami A., Ishida H., Kobo K., Furukawa I., Ikeda Y., Yonaha M., Aniya Y., Ohigashi H. Suppressive effects of Okinawan food items on free radical generation from stimulated leukocytes and identification of some active constituents: implications for the prevention of inflammation-associated carcinogenesis. Asian Pac. J. Cancer Prev. 2005, 6:437-448.
37. Farr J., Hurst S., Skinner M. Anti-inflammatory effects of kiwifruit. Asia Pac. J. Clin. Nutr. 2007, 16:S73.
38. Philpott M., Mackay L., Ferguson L.R., Forbes D., Skinner M. Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutat. Res. 2007, 622:94-102.
39. Zhang X., Goncalves R., Mosser D.M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 2008, 83:14.1.1-14.1.14.
40. Evans G.S., Flint N., Somers A.S., Eyden B., Potten C.S. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J. Cell Sci. 1992, 101:219-231.
41. Vinderola G., Matar C., Perdigon G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors. Clin. Diagn. Lab. Immunol. 2005, 12:1075-1084.
42. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., Ueno K., Watanabe M. Novel cell proliferation and cytotoxicity assays using a tetrazolium salt that produces a water-soluble formazan dye. In Vitro Toxicol. 1995, 8:187-190.
43. Strober W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. 1997, 21. A.3B.1-A.3B.2.
44. Tarpey M.M., Wink D.A., Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R431-444.
45. You M., Lo J.-Y., Wang Y., Yu X. Profiling cytokine levels using a multiplex human cytokine ELISA array. J. Immunol. 2007, 178:94.26.
46. Takakura R., Kiyohara T., Murayama Y., Miyazaki Y., Miyoshi Y., Shinomura Y., Matsuzawa Y. Enhanced macrophage responsiveness to lipopolysaccharide and CD40 stimulation in a murine model of inflammatory bowel disease: IL-10-deficient mice. Inflamm. Res. 2002, 51:409-415.
47. Ruiz P.A., Shkoda A., Kim S.C., Sartor R.B., Haller D. IL-10 gene-deficient mice lack TGF-β/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J. Immunol. 2005, 174:2990-2999.
48. Gao J.J., Filla M.B., Fultz M.J., Vogel S.N., Russell S.W., Murphy W.J. Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1α in mouse macrophages: pivotal role of Stat1α in induction of the inducible nitric oxide synthase gene. J. Immunol. 1998, 161:4803-4810.
49. Edwards J.P., Zhang X., Frauwirth K.A., Mosser D.M. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 2006, 80:1298-1307.
50. Falvo J., Tsytsykova A., Goldfeld A. Transcriptional control of the TNF gene. Curr. Dir. Autoimmun. 2010, 11:27-60.
51. Tsytsykova A.V., Falvo J.V., Schmidt-Supprian M., Courtois G., Thanos D., Goldfeld A.E. Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. J. Biol. Chem. 2007, 282:11629-11638.
52. Rahim S.S., Khan N., Boddupalli C.S., Hasnain S.E., Mukhopadhyay S. Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology 2005, 114:313-321.
53. Tannenbaum S., Wishnok J., Leaf C. Inhibition of nitrosamine formation by ascorbic acid. Am. J. Clin. Nutr. 1991, 53:247S-250.
54. Tepperman B.L., Brown J.F., Korolkiewicz R., Whittle B.J. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J. Pharmacol. Exp. Ther. 1994, 271:1477-1482.
55. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111:871-885.
56. Kimura H., Miura S., Shigematsu T., Ohkubo N., Tsuzuki Y., Kurose I., Higuchi H., Akiba Y., Hokari R., Hirokawa M., Serizawa H., Ishii H. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 1997, 42:1047-1054.
57. Morin M.J., Unno N., Hodin R.A., Fink M.P. Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit. Care Med. 1998, 26:1258-1264.
58. Cavicchi M., Whittle B.J.R. Regulation of induction of nitric oxide synthase and the inhibitory actions of dexamethasone in the human intestinal epithelial cell line, Caco-2: influence of cell differentiation. Br. J. Pharmacol. 1999, 128:705-715.
59. Hruz P., Dann S.M., Eckmann L. STAT3 and its activators in intestinal defense and mucosal homeostasis. Curr. Opin. Gastroenterol. 2010, 26:109-115. 10.1097/MOG.0b013e3283365279.
60. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
61. Strober W., Zhang F., Kitani A., Fuss I., Fichtner-Feigl S. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr. Opin. Gastroenterol. 2010, 26:310-317. 10.1097/MOG.0b013e328339d099.
62. Schoenborn J.R., Wilson C.B. Regulation of interferon-γ during innate and adaptive immune responses. Advances in Immunology 2007, 41-101. Academic Press. W.A. Frederick (Ed.).
63. Montufar-Solis D., Schaefer J., Hicks M.J., Klein J.R. Massive but selective cytokine dysregulation in the colon of IL-10-/- mice revealed by multiplex analysis. Int. Immunol. 2007, 20:141-154.